Skip to main content

Published

Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID: An Adaptive Randomized Trial.
Reis G. Annals of Internal Medicine 2026;:doi:10.7326/ANNALS-26-02144.
[Postacute sequelae of SARS-CoV-2 infection (long COVID) presents a therapeutic challenge, with fatigue being a common, debilitating symptom. Fluvoxamine shows potential for improving long COVID–associated fatigue and quality of life.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Chronic Fatigue Syndrome
Coronavirus Infections
Settings
Community Clinics
General Practice
Hospital Ward
Outpatient Department
Staff Groups
Clinical Scientist
Foundation Year Doctor
Medic
Pharmacist